Phase II Study of Treatment for HPV16+ ASC-US, ASC-H and LSIL

NCT03911076 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

16

Enrollment

OTHER

Sponsor class

Stopped Slow recruitment/funding

Conditions

ASC-US
ASC-H
LSIL

Interventions

BIOLOGICAL: PVX-2
OTHER: Placebo

Sponsor

PapiVax Biotech, Inc.

Collaborators

[object Object]